EPTIS
BAM Logo

Virus Genome Detection – Panel for Viral Meningitis / Encephalitis for Multiplex Tests (433)

[Virusgenom-Nachweis - Panel für virale Meningitis / Enzephalitis für Multiplex Teste (433)]

EPTIS factsheet 1161084 | Last revision 2024-04-16 | URL: https://www.eptis.bam.de/pts1161084 https://www.eptis.bam.de/pts1161084

PT provider
PT provider INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories
Based in Germany
Language(s) German, English
Remarks Infectious material, UN3373, biological substances category B. This program will be completed with currently circulating virus variants. The requirements of the RiliBÄK (Guidelines of the German Medical Association on quality assurance in medical laboratory testing / Bundesärztekammer) will be considered for the detection of the above-mentioned pathogens. This EQA scheme will contain each of the above-mentioned pathogens at least once a year. It is recommended to participate at both EQA scheme terms. Please note: Only results of multiplex tests will be accepted for EQA scheme 433. This multiplex EQA scheme is not suitable for (i) ´singleplex´ PCRs, (ii) tests for antigen detection, (iii) testing of sensitivity and (iv) typing. For this purpose, we refer to the INSTAND EQA schemes for the corresponding viruses. The interdisciplinary, non-profit, scientific and medical association INSTAND e. V. is a reference institution for the quality control of medical laboratories. It is one of four German reference institutions responsible for the organization of external quality assessment (EQA) schemes for quality control in medical laboratories. You can register for EQAs, submit your results and later download your evaluation documents via https://rv-online.instandev.de. This price applies exclusively to orders placed via INSTAND e.V. Prices and services may differ for orders placed via distributors. Our newest EQA program can also be found on our website: https://www.instand-ev.de/en/instand-eqas/eqa-program/
Keywords
Product groups Human test material
Testing fields Medical analysis
Technical details
Test item Tested property Testing method
4 samples of 1.5 mL lyophilized cell culture lysates PCR and NAT for simultaneous qualitative detection of adenoviruses , cytomegalovirus, enteroviruses , Epstein Barr virus, herpes simplex virus type 1, herpes simplex virus type 2, human herpesvirus 6, parechovirus and varicella zoster virus, respectively. -
Aims of the PT scheme
Target group of participants
Linked to specific legislation / standards
Additional, subsidiary aims
Number of participants 50-100
Accredited or otherwise reviewed by a 3rd party

Accredited by DAkkS (Germany) on the basis of ISO/IEC 17043

German Bundesärztekammer (General medical Council)

Operation is commissioned / requested by
Fees and frequency
Participation fee 771 Euro / Survey
Regularly operated Yes (2 times per year)
Year of first operation Experience with operation of ILCs since 1968
Contact details of the PT provider
Provider Contact person
INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories
P.O.Box 250211, Ubierstrasse 20
40223 Düsseldorf
Germany

Phone: +49-211-159213-0
Fax:
Web: http://www.instandev.de/ http://www.instandev.de/
Dr. rer. nat. Nathalie Weiss
Phone: +49-211-159213430
Fax:
Email: weiss@instand-ev.de weiss@instand-ev.de
If you find any mistakes please contact the responsible EPTIS coordinator in Germany, Mr Johannes van de Kreeke. Mr Johannes van de Kreeke.
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.23-SNAPSHOT.20230502124635-7925ae379a631fc1ececff45d2921c8db38877d5